New drugs approved for advanced BRCA-positive prostate cancer
Defective BRCA genes are well known for their ability to cause breast and ovarian cancers in women. But these same gene defects are also strong risk factors for aggressive prostate cancer in men. About...
View ArticleA new hormonal therapy for prostate cancer is under expedited FDA review
In June, the US Food and Drug Administration (FDA) launched an accelerated review of a promising new drug for advanced prostate cancer. Called relugolix, it suppresses testosterone and other hormones...
View ArticleHormonal treatments for prostate cancer are often given late
Men with advanced prostate cancer are typically treated with drugs that cause testosterone levels to plummet. Testosterone is a hormone that fuels growing prostate tumors, so ideally this type of...
View ArticleHormonal treatments for prostate cancer may prevent or limit COVID-19 symptoms
Men have roughly twice the risk of developing severe disease and dying from COVID-19 than women. Scientists say this is in part because women mount stronger immune reactions to the disease’s microbial...
View ArticleNew online model identifies which men can have fewer biopsies on active...
During the last decade, more men with favorable-risk prostate cancer that is unlikely to cause symptoms and spread have opted for a monitoring approach called active surveillance (AS) instead of...
View ArticleThe sequence of hormonal therapy and radiation affects outcomes in men...
A common treatment for men with intermediate-risk prostate cancer is to combine radiation with drugs that block testosterone — a hormone that makes the tumors grow faster. (This type of treatment is...
View ArticleNew high-resolution imaging scans approved for use in prostate cancer
Imagine trying to find a single match from a book of matches in a large room. Not an easy task, right? But if the lights were dimmed and the match was lit, then its location would be immediately...
View ArticleHormonal therapies for advanced prostate cancer linked to a higher risk of...
Falls rank among the top causes of death and injuries among the elderly, and the risk increases significantly in older people being treated for cancer. Now, investigators are reporting that a newer...
View ArticleImproving PET scans are good news for doctors and patients alike
A recent blog post discussed a newly approved imaging agent with an unwieldy name: gallium-68 PMA-11. Delivered in small amounts by injection, this minimally radioactive tracer sticks to prostate...
View ArticleAn emerging treatment option for men with recurring prostate cancer after...
Prostate cancer is often a multifocal disease, meaning that several tumors can be present in different parts of gland at the same time. Not all of these tumors are equally problematic, however. And...
View Article
